Microba Life Sciences (ASX:MAP) appointed Geoffrey Cockerill as interim chief executive, effective Sept. 29, following CEO Luke Reid's medical leave, according to a Friday filing with the Australian bourse.
Cockerill most recently served as CEO of Vitura Health (ASX:VIT), the filing said.